DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Cellulite and Magnetic Resonance Imaging

Information source: Brazilian Center for Dermatological Studies
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cellulite

Phase: N/A

Status: Terminated

Sponsored by: Brazilian Center for Dermatological Studies

Summary

The purpose of this study is to compare the anatomy of subcutaneous structures in areas with and without cellulite on the buttocks of same subjects with a non invasive technique, Magnetic Resonance Imaging.

Clinical Details

Official title: Anatomy of Subcutaneous Structures in Areas With and Without Cellulite Depressions by Magnetic Resonance Imaging

Study design: Case-Only, Prospective

Primary outcome: The presence and characteristics of the fibrous septa in areas with and without cellulite.

Secondary outcome: The characteristics of the subcutaneous tissue in areas with and without cellulite.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Written Informed Consent;

- Subjects agreeing to take part of all procedures of the study, after being fully

informed on the objectives and nature of the investigations;

- Healthy female subjects over 18 years;

- Subjects presenting cellulite on the buttocks;

- Medical history and physical examination which, based on the investigator's opinion,

do not prevent the patient from taking part in the study and use the product under investigation;

- Female subjects of childbearing age should present a negative urine pregnancy test and

should be using an effective contraceptive method (3 months before the enrollment until the end of the study);

- Availability of the subject throughout the duration of the study (180 days);

- Subjects with sufficient schooling and awareness to enable them to cooperate to the

degree required by this protocol.

Exclusion Criteria:

- Pregnant women or women intending to become pregnant during the study (next 3

months);

- Subjects participating in other clinical trials;

- Any condition that, in the opinion of the investigator, can compromise the evaluation

of the study.

Locations and Contacts

Additional Information


Last updated: March 13, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009